PPA
IDXX icon

Pacific Point Advisors’s Idexx Laboratories IDXX Stock Holding History

Pacific Point Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
2,385
+5
+0.2% +$3.21K 0.71% 43
2025
Q4 		$1.61M Sell
2,380
-102
-4% -$69.5K 0.86% 28
2025
Q3 		$1.59M Sell
2,482
-1,154
-32% -$700K 0.93% 30
2025
Q2 		$1.95M Buy
3,636
+179
+5% +$85.6K 1.06% 16
2025
Q1 		$1.45M Buy
3,457
+274
+9% +$119K 0.81% 33
2024
Q4 		$1.48M Buy
+3,183
New +$1.4M 0.9% 19

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacific Point Advisors's IDXX Position: Q1 2026 in Review

Pacific Point Advisors increased its Idexx Laboratories (IDXX) stake by 0.21% in Q1 2026, buying an estimated $3.21K and bringing the position to 2,385 shares worth $1.34M. The position accounts for 0.71% of the portfolio, ranked #43.

Pacific Point Advisors first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.95M in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Pacific Point Advisors held 2,385 shares of Idexx Laboratories worth $1.34M as of Q1 2026.
  • Pacific Point Advisors bought 5 Idexx Laboratories shares in Q1 2026, an estimated $3.21K.
  • Idexx Laboratories made up 0.71% of Pacific Point Advisors's portfolio in Q1 2026, its #43 holding.
  • Pacific Point Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Pacific Point Advisors's Idexx Laboratories position peaked at $1.95M in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Pacific Point Advisors's 13F filing for Q1 2026, filed 4 May 2026.